Cytogenetic and molecular cytogenetic studies of a variant of t(21;22), ins(22;21)(q12;q21q22), with a deletion of the 3′ EWSR1 gene in a patient with Ewing sarcoma

Cancer Genetics and Cytogenetics

Volumn 159, Issue 2, 2005, Pages 177-180

  Lee, Jiyun ^a   Hopcus Niccum, Deborah J ^a   Mulvihill, John J ^a   Li, Shibo ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; CHILD; CHROMOSOME 21Q; CHROMOSOME 22; CHROMOSOME PAINTING; CYTOGENETICS; DNA FLANKING REGION; EWING SARCOMA; EWSR1 GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; GENE INSERTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

CALMODULIN-BINDING PROTEINS; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; RNA-BINDING PROTEINS; SARCOMA, EWING'S; THORACIC WALL; TRANSLOCATION, GENETIC;

EID: 19344373528     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.11.003     Document Type: Article

References (17)

1. J. Ewing Diffuse endothelioma of bone Proc N Y Path Soc 21 1921 17 24
2. A. Aurias, C. Rimbaut, D. Buffe, J. Dubousset, and A. Mazabraud Translocations of chromosome 22 in Ewing's sarcoma. An analysis of 4 fresh tumors N Engl J Med 309 1983 496 497
3. C. Turc-Carel, I. Philip, M.P. Berger, T. Philip, and G.M. Lenoir Translocation (11;22) (q24;q12) in Ewing's sarcoma cell lines N Engl J Med 309 1983 497 498
4. A.A. Sandberg, and J.A. Bridge Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors Cancer Genet Cytogenet 123 2000 1 26
5. O. Delattre, J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jog, G. Rouleau, A. Aurias, and G. Thomas Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in tumors Nature 359 1992 162 165
6. I.-S. Jeon, J.N. Davis, B.S. Braun, F.E. Sublett, M.F. Roussel, C.T. Denny, and D.N. Shapiro A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1 Oncogene 10 1995 1229 1234
7. Y. Kaneko, H. Kobayashi, M. Handa, N. Satake, and N. Maseki EWS-ERG fusion transcript produced by chromosomal insertion in a Ewing sarcoma Gene Chromosomes Cancer 18 1997 228 231
8. M. Peter, J. Couturier, H. Helene Pacquement, J. Michon, G. Thomas, H. Magdelenat, and O. Delattre A new member of the ETS family fused to EWS in Ewing tumors Oncogene 14 1997 1159 1164
9. W.A. May, S.L. Lessnick, B.S. Braun, M. Klemsz, B.C. Lewis, L.B. Lunsford, R. Hromas, and C.T. Denny The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 Mol Cell Biol 3 1993 7393 7398
10. J.R. Batanian, J.A. Bridge, R. Wickert, C. Vogler, B. Gadre, and Y. Huang EWS/FLI-1 fusion signal inserted into chromosome 11 in one patient with morphologic features of Ewing sarcoma, but lacking t(11;22) Cancer Genet Cytogenet 133 2002 72 75
11. M. Urioste, A. Martinez-Ramirez, J.C. Cigudosa, M.S. Mateo, P. Martinez, T. Contra, and J. Benitez Identification of ins(8;21) with AML1/ETO fusion in acute myelogenous leukemia M2 by molecular cytogenetics Cancer Genet Cytogenet 133 2002 83 86
12. R. Rolston, K.E. Weck, J.M. Tersak, M.E. Sherer, and K. Cumbie Shekhter-Levin S. New cytogenetic variant, insertion (15;17)(q22;q12q21), in an adolescent with acute promyelocytic leukemia Cancer Genet Cytogenet 134 2002 55 59
13. A. Aventin, R. La Starza, J. Nomdedeu, S. Brunet, J. Sierra, and C. Mecucci Typical CBFbeta/MYH11 fusion due to insertion of the 3′-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22 Cancer Genet Cytogenet 123 2000 137 139
14. V. Najfeld High performance of the BCR/ABL-extra sensitive (ES) probe for detection of der(9q) deletion in t(9;22)(q34;q11.2) Cancer Genet Cytogenet 132 2002 171
15. C.T. Storlazzi, G. Specchia, L. Anelli, F. Albano, D. Pastore, A. Zagaria, M. Rocchi, and V. Liso Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients Genes Chromosomes Cancer 35 2002 271 276
16. P.B. Sinclair, E.P. Nacheva, M. Leversha, N. Telford, J. Chang, A. Reid, A. Bench, K. Champion, B. Huntly, and A.R. Gree Large deletion at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia Blood 95 2000 738 743
17. N. Cohen, G. Rozenfeld-Granot, I. Hardan, F. Brok-Simoni, N. Amariglio, G. Rcchavi, and L. Trakhtcenbrot Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene. Expression profiling, resistance to interferon therapy, and poor prognosis Cancer Genet Cytogenet 128 2001 114 119